NCT00219648View on ClinicalTrials.gov

Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With PEP03 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE2UnknownINTERVENTIONAL
Timeline

Start Date

September 30, 2004

Conditions
COPD
Interventions
DRUG

PEP03

Trial Locations (1)

Unknown

RECRUITING

Chang Gung Memorial Hospital, Taipei

Sponsors

Lead Sponsor

PharmaEngine
All Listed Sponsors
lead

PharmaEngine

INDUSTRY

NCT00219648 - Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With PEP03 in Patients With Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter